GIST
Clinical trials for GIST explained in plain language.
Never miss a new study
Get alerted when new GIST trials appear
Sign up with your email to follow new studies for GIST, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for patients whose stomach cancer stopped responding to standard drug
Disease control OngoingThis study is testing whether adding a new drug called bezuclastinib to an existing cancer drug (sunitinib) can help control advanced gastrointestinal stromal tumors (GIST) that have started growing again on sunitinib alone. It will involve about 40 adult patients who have a spec…
Matched conditions: GIST
Phase: PHASE2 • Sponsor: Sarcoma Alliance for Research through Collaboration • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
New hope for Tough-to-Treat stomach cancer: Head-to-Head drug battle
Disease control OngoingThis study compares two drugs, ripretinib and sunitinib, for patients with advanced gastrointestinal stromal tumor (GIST) whose cancer has grown despite initial treatment with imatinib. It specifically targets patients whose tumors have certain genetic mutations. The goal is to s…
Matched conditions: GIST
Phase: PHASE3 • Sponsor: Deciphera Pharmaceuticals, LLC • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC